Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;10(3):378–384. doi: 10.1111/j.1750-3639.2000.tb00269.x

Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry

Ronald L Hamilton 1,✉
PMCID: PMC8098522  PMID: 10885656

Abstract

Antibodies to α‐synuclein (AS) now provide a sensitive and specific method for the detection of Lewy bodies (LBs) and their use will allow a more accurate determination of the prevalence of LBs in Alzheimer's Disease (AD). Studies using AS immunohistochemistry (IHC) have found LBs in the amygdala of over 60% early onset familial AD and in 50% of Down's syndrome patients with AD, however, no studies have reported the use of AS IHC to detect LBs in a large cohort of sporadic AD. This study examined 145 sporadic AD cases diagnosed using CERAD criteria from 1995–1999 for the presence of LBs using AS IHC. AS IHC detected LBs in 88/145 (60.7%) of sporadic AD cases. Similarly, LBs were found in 56.8% of the 95 cases fulfilling the more stringent NIA‐RI criteria for the diagnosis of AD (Braak stage 5–6). In all cases with LBs, the amygdala was involved and LBs were always most numerous in this area, however, in some cases LBs in the substantia nigra were rare or not present. In conclusion, this study found that AS IHC detects LBs in the majority of sporadic AD cases and that the amygdala is the most commonly affected region.

Full Text

The Full Text of this article is available as a PDF (70.4 KB).

References

  • 1. Anonymous (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18: S1–2. [PubMed] [Google Scholar]
  • 2. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha‐synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152: 879–884. [PMC free article] [PubMed] [Google Scholar]
  • 3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer‐related changes. Acta Neuropath 82: 239–259. [DOI] [PubMed] [Google Scholar]
  • 4. Braak H, Braak E, Yilmazer D, De Vos RA, Jansen EN, Bohl J (1996) Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Trans 103: 455–490. [DOI] [PubMed] [Google Scholar]
  • 5. Dickson DW (1990) Lewy body variant [letter; comment]. Neurology 40: 1147–1150. [DOI] [PubMed] [Google Scholar]
  • 6. Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Ksiezak‐Reding H, Davies P, Yen SH (1989) Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropath 78: 572–584. [DOI] [PubMed] [Google Scholar]
  • 7. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13: 179–189. [DOI] [PubMed] [Google Scholar]
  • 8. Forstl H, Burns A, Luthert P, Cairns N, Levy R (1993) The Lewy‐body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychia 162: 385–392. [DOI] [PubMed] [Google Scholar]
  • 9. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ (1994) Clinical‐neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51: 888–895. [DOI] [PubMed] [Google Scholar]
  • 10. Gomez‐Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT (1999) Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 53: 1284–1291. [DOI] [PubMed] [Google Scholar]
  • 11. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 40: 1–7. [DOI] [PubMed] [Google Scholar]
  • 12. Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque‐only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 52: 648–654. [DOI] [PubMed] [Google Scholar]
  • 13. Hansen LA, Samuel W (1997) Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 48: 126–132. [DOI] [PubMed] [Google Scholar]
  • 14. Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh‐Bohmer KA, Peterson B, Pieper C (1999) Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology 52: 1839–1844. [DOI] [PubMed] [Google Scholar]
  • 15. Hughes A, Daniel S, et al (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 50: 140–148. [DOI] [PubMed] [Google Scholar]
  • 16. Ince P, Irving D, McArthur F, Perry R (1991) Quantitative neuropathological study of Alzheimer‐type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, of senile demntia of Lewy type, Parkinson's disease and nondemented elderly control patients. J Neurological Sci 142–152. [DOI] [PubMed]
  • 17. Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA (1995) Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia 6: 162–168. [DOI] [PubMed] [Google Scholar]
  • 18. Ince PG, Perry EK, Morris CM (1998) Dementia with Lewy bodies. A distinct non‐Alzheimer dementia syndrome Brain Pathol 8: 299–324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Jakes R, Crowther R, Lee V‐Y, Trojanowski J, Iwatsubo T, Goedert M (1999) Epitope mapping of LB509, a monoclonal antibody against human α‐synuclein. Neurosci Letters 269: 13–16. [DOI] [PubMed] [Google Scholar]
  • 20. Kazee AM, Han LY (1995) Cortical Lewy bodies in Alzheimer's disease. Arch Path Lab Med 119: 448–453. [PubMed] [Google Scholar]
  • 21. Kosaka K, Iseki E, Odawara T, Yamamoto T (1996) Cerebral type of Lewy body disease. Neuropathol 16: 32–35. [Google Scholar]
  • 22. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin‐Austen RB (1989) Diffuse Lewy body disease: correlative neuropathology using anti‐ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiat 52: 1236–1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Lindboe CF, Hansen HB (1998) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 17: 204–209. [PubMed] [Google Scholar]
  • 24. Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, B OC, Pollen DA, George‐Hyslop P St. Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ (1998) Lewy bodies contain altered alpha‐synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153: 1365–1370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ (1999) Antibodies to alpha‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 45: 353–357. [DOI] [PubMed] [Google Scholar]
  • 26. Lopez O, Hamilton R, Becker J, Wisniewski S, Kaufer D, DeKosky S (1998) Clinical features and predictors of progression in patients with Alzheimer's disease and with the Lewy body variant of Alzheimer's disease (abstract). Neurology 50 (suppl 4): A182. [Google Scholar]
  • 27. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH (1994) An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44: 872–877. [DOI] [PubMed] [Google Scholar]
  • 28. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, De Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113–1124. [DOI] [PubMed] [Google Scholar]
  • 29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E (1984) Clinical diagnosis of Alzheimer's Disease: report of the NINCDS/ADRDA Workgroup under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939–944. [DOI] [PubMed] [Google Scholar]
  • 30. Mega MS, Masterman DL, Benson DF, Vinters HV, Tomiyasu U, Craig AH, Foti DJ, Kaufer D, Scharre DW, Fairbanks L, Cummings JL (1996) Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 47: 1403–1409. [DOI] [PubMed] [Google Scholar]
  • 31. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479–486. [DOI] [PubMed] [Google Scholar]
  • 32. Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 51: 351–357. [DOI] [PubMed] [Google Scholar]
  • 33. Rezaie P, Cairns NJ, Chadwick A, Lantos PL (1996) Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Letters 212: 111–114. [DOI] [PubMed] [Google Scholar]
  • 34. Sugiyama H, Hainfellner JA, Yoshimura M, Budka H (1994) Neocortical changes in Parkinson's disease, revisited. Clin Neuropathol 13: 55–59. [PubMed] [Google Scholar]
  • 35. Victoroff J, Mack WJ, Lyness SA, Chui HC (1995) Multicenter clinicopathological correlation in dementia. Am J Psychiat 152: 1476–1484. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES